Willis Towers Watson Acquires TRANZACT from CD&R

March 31, 2019

Willis Towers Watson has acquired TRANZACT, a U.S. direct-to-consumer sales and marketing platform for Medicare and individual life insurance, from private equity firm Clayton, Dubilier & Rice for approximately $1.2–1.3 billion (including potential earn-out). The acquisition adds TRANZACT's technology-driven lead generation, sales execution and analytics capabilities — and its ~1,300 employees (including ~850 licensed agents) — to Willis Towers Watson's Benefits Delivery and Administration business to accelerate its direct-to-consumer strategy.

Buyers
Willis Towers Watson
Targets
TRANZACT
Sellers
Clayton, Dubilier & Rice (CD&R)
Location
New Jersey, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.